Navigation Links
March of Dimes awards $250,000 prize to scientists unraveling the causes of muscular dystrophy
Date:5/2/2009

BALTIMORE, MAY 3, 2009 Two scientists whose work has led to new and better ways to diagnose and potentially treat muscular dystrophy have been chosen to receive the 2009 March of Dimes Prize in Developmental Biology.

Kevin P. Campbell, Ph.D. and Louis M. Kunkel, Ph.D., will share the 2009 March of Dimes Prize for their pioneering work identifying the genes and proteins that cause muscular dystrophy, a disorder in which the muscles progressively degenerate. More than 250,000 Americans are affected by the nine forms of muscular dystrophy and other related neuromuscular disorders. Among this group are facioscapulohumeral muscular dystrophy and limb girdle muscular dystrophy, as well as childhood conditions such as Duchenne and Becker muscular dystrophies and congenital muscular dystrophy.

The March of Dimes Prize is a $250,000 cash award and a silver medal in the design of the Roosevelt dime, in honor of President Franklin Delano Roosevelt, who founded the March of Dimes. The Prize will be awarded to Dr. Campbell and Dr. Kunkel at a gala black tie dinner and ceremony at the InterContinental Harbor Court here. CBS sportscaster Greg Gumbel, member of the March of Dimes national Honorary Board of Trustees, will host the ceremony.

"Dr. Campbell and Dr. Kunkel have provided crucial insights into how muscular dystrophies develop the critical step needed to develop diagnostic tools and potential treatments," said Michael Katz, MD, senior vice president for Research and Global Programs at the March of Dimes. "Based on their pioneering research, physicians all over the world now are better able to help families and children affected by these disorders. Currently, there are several promising clinical trials of new treatments in progress based on the achievements of these two scientists."

Dr. Campbell, a Howard Hughes Medical Institute investigator, is professor and head of Molecular Physiology and Biophysics at the University of Iowa Roy J. and Lucille A. Carver College of Medicine. He is also the Roy J. Carver Chair of Molecular Physiology and Biophysics and Director of the Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center. His work unraveled the molecular mechanisms of muscular dystrophies.

Dr. Kunkel, also a Howard Hughes Medical Investigator, is professor of Pediatrics and Genetics at Harvard Medical School as well as Director of the Program in Genomics at The Children's Hospital in Boston, Massachusetts. More than 20 years ago, Dr. Kunkel identified dystrophin, the gene encoding the protein that is altered in boys with Duchenne and Becker forms of muscular dystrophy.

The March of Dimes Prize in Developmental Biology has been awarded annually since 1996 to investigators whose research has profoundly advanced the science that underlies the understanding of birth defects. The March of Dimes Foundation created the Prize as a tribute to Dr. Jonas Salk, who received Foundation support for his work to create a polio vaccine.

Also on May 3, Dr. Campbell and Dr. Kunkel will deliver the Fourteenth Annual March of Dimes Prize Lectures at the Baltimore Convention Center during the 2009 Annual Meeting of the Pediatric Academic Societies.


'/>"/>

Contact: Elizabeth Lynch
elynch@marchofdimes.com
914-997-4286
March of Dimes Foundation
Source:Eurekalert  

Related biology news :

1. Roberta A. Pagon receives lifetime award in genetics from March of Dimes
2. AGU journal highlights -- March 25, 2009
3. Highlights from the March editions of ESA journals
4. American Chemical Societys weekly PressPac -- March 11, 2009
5. Science returns to the Capitol Hill spotlight at March 24 exhibition
6. AGU journal highlights -- March 12, 2009
7. Prominent climate researcher to speak at UH on global warming March 5
8. News from the March 2009 Journal of the American Dietetic Association
9. Story tips from the Departments of Energys Oak Ridge National Lab -- March 2009
10. BioScience tip sheet, March 2009
11. Public Policy Center hosts flood symposium March 10-12
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
March of Dimes awards $250,000 prize to scientists unraveling the causes of muscular dystrophy
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a provider ... MegaMatcher Automated Biometric Identification System (ABIS) , ... multi-biometric projects. MegaMatcher ABIS can process multiple complex ... any combination of fingerprint, face or iris biometrics. ... SDK and MegaMatcher Accelerator , which ...
(Date:4/26/2016)... India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a product ... and Onegini today announced a partnership to integrate ... solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... to provide their customers enhanced security to access ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ... advised by its major shareholders, Clean Technology Fund I, ... United States based venture capital funds which ... Biorem (on a fully diluted, as converted basis), that ... of their entire equity holdings in Biorem to TUS ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... will join the faculty of the University of North Carolina Kenan-Flagler Business ... strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s international ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers ... 5000 and the 6000i models are higher end machines that use the more unconventional ... spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci has ...
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
Breaking Biology Technology: